ImmunityBio, Inc. (IBRX) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

From a roadmap perspective, the setup is boxed by support near 5.21 and resistance around 7.37. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis. Pattern invalidation sits near 1.89, so a violation there would materially change the current setup narrative.

📊 Technical Summary

ImmunityBio, Inc. (IBRX) finished the session at 7.10 (+2.01%). Price has slipped under the 50-day average but remains above the 200-day average, leaving the longer-term structure intact even as medium-term momentum softens. 20-day momentum is running at -0.56%, with price remains inside its roughly 52-week range (1.89–11.55), while ATR14 volatility is elevated at roughly 7.21% of price. RSI(14) is 44.6, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram is negative and weakening further, which reflects continued downside pressure. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. From a pattern perspective, the main active signal is Double bottom. The most important nearby levels are support at 5.21 and resistance at 7.37. Clearing resistance would improve continuation odds, while slipping below support would weaken the present setup. On the fundamentals side, the latest snapshot shows Revenue: 32.06M · Net income: -67.27M · EPS (basic): -0.07. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.

Explore more